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ABSTRACT: In the last years, outer membrane vesicles have
attracted a lot of attention for the development of vaccines
against bacterial pathogens. Extracellular vesicles can be
obtained in high yields by genetic mutations, resulting in
generalized modules for membrane antigens (GMMA).
Methods to check the quality, consistency of production,
and stability of GMMA vaccines are of fundamental
importance. In this context, analytical methods for size
distribution determination and verifying the integrity and
possible aggregation of GMMA particles are strongly needed.
Herein, GMMA particle size distribution has been evaluated by
means of three diﬀerent techniques. Dynamic light scattering
(DLS), multiangle light scattering (MALS) coupled with high-
performance liquid chromatography−size exclusion chromatography (SEC), and nanoparticle tracking analysis (NTA) have been
compared to characterize GMMA from diﬀerent mutants of Salmonella typhimurium and Salmonella enteritidis strains. We found
that the presence of O-antigen chains on GMMA determined higher Z-average diameters by DLS compared to size estimation by
MALS and that the hydrodynamic diameter increased with the number of O-antigen chains per GMMA particle. In the case of
SEC-MALS, the size of the whole population better reﬂects the size of the most abundant particles, whereas DLS diameter is
more inﬂuenced by the presence of larger particles in the sample. SEC-MALS and NTA are preferable to DLS for the analysis of
bimodal samples, as they better distinguish populations of diﬀerent size. MALS coupled to a size exclusion chromatography
module also allows checking the purity of GMMA preparations, allowing determination of generally occurring contaminants such
as soluble proteins and DNA. NTA permits real-time visualization with simultaneous tracking and counting of individual
particles, but it is deeply dependent on the choice of data analysis parameters. All of the three techniques have provided
complementary information leading to a more complete characterization of GMMA particles.
■ INTRODUCTION
Outer membrane vesicles (OMV) are small bilayered
membrane structures naturally released from the cell surface
of the Gram-negative bacteria. Simplicity of production and
high immunogenicity of these particles, which mimic those of
the external surface of bacteria, have made OMV particularly
attractive for the development of vaccines against bacterial
pathogens.1 Extracellular vesicles can be obtained in high
yields2 by genetic manipulation, resulting in generalized
modules for membrane antigens (GMMA).3,4 Further muta-
tions are usually introduced to reduce GMMA toxicity by
modifying, for example, the acylation pattern of lipid A.5,6
Recently, a bivalent formulation of Salmonella typhimurium and
Salmonella enteritidis GMMA has been proposed as a vaccine
candidate against nontyphoidal Salmonella, the leading cause of
morbidity and death in sub-Saharan Africa, for which a vaccine
is not yet available.7
GMMA are complex systems and an in-depth character-
ization is needed to assure consistency of production and
stability over time. Particle size distribution is among the
characteristics of GMMA to be investigated for their full
characterization.8,9
A number of techniques are available for particle size
measurement,10−12 including dynamic light scattering (DLS),
multiangle light scattering (MALS), and nanoparticle tracking
analysis (NTA).
DLS, also known as photon correlation spectroscopy or
quasielastic light scattering (QELS), is a popular and routine
technique used for the measurement of size distribution of
small particles in suspension since 1960s.11,13,14 This technique
is used to obtain a mean hydrodynamic diameter (Z-average
diameter) and a polydispersity index (PDI), describing the
amplitude of the distribution. Hydrodynamic diameter is
calculated using the Stokes−Einstein equation, obtaining the
diﬀusion coeﬃcient by measuring intensity ﬂuctuations of
scattered light produced by particles as they undergo Brownian
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motion. MALS represents a static light scattering techni-
que.15,16 Depending on the analysis model, MALS determines,
using the angular dependence of the time-averaged scattering
intensity, the geometric radius (Rgeo) or the root-mean-square
radius, commonly known as the radius of gyration (Rg).
NTA is an alternative light-scattering technique useful for the
evaluation of size and number of individual particles,17 ranging
from 10 to 2000 nm in size, in liquids.8,18,19 As for the DLS, the
particle diameter is calculated using the Stokes−Einstein
equation, but by measuring directly the diﬀusion coeﬃcient
of particles moving under Brownian motion, relating the rate of
particle motion to particle size.20,21
Here, DLS, HPLC-SEC/MALS, and NTA were applied for
determining particle size distribution of GMMA produced by
diﬀerent S. typhimurium- and S. enteritidis-mutated strains.
Advantages and limitations of each type of methods are
discussed.
■ RESULTS AND DISCUSSION
Size distribution analysis was performed on GMMA from
diﬀerent S. typhimurium- and S. enteritidis-mutated strains. In
particular, STm 1418 ΔtolR GMMA and STm 1418 ΔtolR
ΔwbaP GMMA were selected to see the diﬀerences between
OAg-positive (OAg+) and OAg-negative (OAg−) GMMA. SEn
618 ΔtolR ΔmsbB ΔpagP GMMA and STm 2192 ΔtolR ΔpagP
ΔmsbB represent the possible candidate vaccines for use in
humans, where the deletion of msbB and pagP was used to
minimize reactogenicity.
Size Distribution Analysis by DLS. SEn 618 ΔtolR
ΔmsbB ΔpagP GMMA exhibited a Z-average diameter of
111.07 nm. STm 2192 ΔtolR ΔpagP ΔmsbB and STm 1418
ΔtolR GMMA were characterized by a Z-average diameter of
103.47 and 91.53 nm, respectively (Table 1, Figure 1A).
No diﬀerences were found by analyzing the samples at diﬀerent
protein concentrations (in the range 50−200 μg/mL). PDI
values were in the range 0.15−0.19, indicating a moderate
polydispersity for the GMMA samples analyzed.
STm 1418 ΔtolR ΔwbaP GMMA were characterized by a
smaller size of 57.60 nm and a higher PDI of 0.26 (Figure 1A,
Table 1).
For SEn 618 ΔtolR ΔmsbB ΔpagP and STm 2192 ΔtolR
ΔpagP ΔmsbB GMMA, three adjacent populations at diﬀerent
molecular mass were separated by HPLC-SEC, and further
analyzed by DLS. The Z-average diameter and the PDI values
of the collected fractions are summarized in Table 1.
High molecular mass (HMM) fractions, both for S. enteritidis
618 and S. typhimurium 2192 GMMA, showed a particle size
distribution similar to that found for unfractionated GMMA.
Fractions at the center of the distribution (MMM) and low
molecular mass fractions (LMM) showed decreased hydro-
dynamic diameters with respect to the whole GMMA
population.
Size Distribution Analysis by SEC-MALS. All of the
GMMA preparations were analyzed by SEC-MALS by applying
the “sphere” model. The calculated diameters, averaged with
diﬀerent weights (2 × Rn, 2 × Rw, and 2 × Rz), are reported in
Table 2.
SEn 618 ΔtolR ΔmsbB ΔpagP, STm 2192 ΔtolR ΔpagP
ΔmsbB, and STm 1418 ΔtolR GMMA were characterized by a
similar 2 × Rz value (Table 2, Figure 1B).
Unlike DLS, showing one single population, SEC-MALS
analysis of STm 1418 ΔtolR ΔwbaP GMMA revealed a bimodal
distribution with the maxima at 2 × Rz = 55.40 and 101.80 nm,
respectively (Figure 1B).
Samples derived from HPLC-SEC fractionation of SEn 618
ΔtolR ΔmsbB ΔpagP and STm 2192 ΔtolR ΔpagP ΔmsbB
GMMA were also analyzed by SEC-MALS. Results relative to
the collected fractions are summarized in Table 2.
Size Distribution Analysis by NTA. All of the GMMA
samples were analyzed by NTA. Screen gain and camera level
(shutter speed and camera gain) were set at values 2 and 16,
respectively, and selected based on the visually brightest
detection of particles without the occurrence of abundant
overscattering events.
After performing a ﬁrst set of experiments, we veriﬁed that
the detection threshold needed to be selected by the operator,
according to the sample and its dilution, to have consistent
results both in terms of size and particles counting.
Similar results, both in terms of size and number of particles
per mg of GMMA proteins, were obtained by analyzing SEn
618 ΔtolR ΔmsbB ΔpagP GMMA at diﬀerent dilutions (Table
3).
Similar data were collected for all of the GMMA samples and
average results are summarized in Table 4. Standard deviation
(SD), D10, D50, and D90 percentile values showed that
GMMA samples were quite polydisperse.
The analysis of more homogeneous samples was performed
by analyzing the MMM fractions from the SEC fractionation of
GMMA (Table 4). More similarity was observed between mean
and mode hydrodynamic diameter compared to what was
found for the unfractionated GMMA. Lower SD and D90 and
higher D10 values clearly showed that a more homogeneous
sample was obtained.
The mode diameters of the unfractionated samples were
similar to the mean values of the fraction corresponding to the
central area of the GMMA samples. NTA analysis of STm 1418
ΔtolR ΔwbaP GMMA revealed a high diﬃculty in proper
tracking and enumerating of the particles, probably due to their
smaller dimensions and higher polydispersity. Table 4 reports
the mean and mode values calculated for the entire population.
However, NTA, similar to SEC-MALS, was able to distinguish a
major peak with a mode value of 55 nm and a less abundant
peak with a mode value of 85 nm.
Comparison of DLS, MALS, and NTA Results. Dimen-
sional analyses performed on SEn 618 ΔtolR ΔmsbB ΔpagP,
STm 2192 ΔtolR ΔpagP ΔmsbB, STm 1418 ΔtolR, and STm
1418 ΔtolR ΔwbaP GMMA using the three diﬀerent methods
are summarized in Table 5.
Table 1. Z-Average Diameter and Relative PDI of S.
enteritidis and S. typhimurium GMMA Samples Analyzed by
DLS
GMMA fraction
Z-average diameter
(nm) PDI
SEn 618 ΔtolR ΔmsbB
ΔpagP
whole population 111.07 ± 0.93 0.15
HMM 116.30 ± 0.89 0.14
MMM 91.28 ± 0.23 0.08
LMM 84.10 ± 0.62 0.16
STm 2192 ΔtolR ΔpagP
ΔmsbB
whole population 103.47 ± 0.69 0.19
HMM 100.27 ± 0.21 0.09
MMM 81.69 ± 0.25 0.06
LMM 77.46 ± 1.15 0.16
STm 1418 ΔtolR whole population 91.53 ± 0.46 0.18
STm 1418 ΔtolR ΔwbaP whole population 57.60 ± 0.53 0.26
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Analysis of the whole GMMA populations gave NTA mean
diameters similar to Z-average diameters by DLS. MMM
populations, obtained after the fractionation of GMMA
samples, showed similar hydrodynamic diameters, by DLS,
Figure 1. (A) DLS size distribution of SEn 618 ΔtolR ΔmsbB ΔpagP (red), STm 2192 ΔtolR ΔpagP ΔmsbB (green), STm 1418 ΔtolR (blue), and
STm 1418 ΔtolR ΔwbaP GMMA (black). (B) SEC-MALS chromatogram of SEn 618 ΔtolR ΔmsbB ΔpagP and STm 1418 ΔtolR ΔwbaP GMMA,
with indication of the Rz value corresponding to the apex of light scattering detection. (C) NTA graph of SEn 618 ΔtolR ΔmsbB ΔpagP GMMA (as
an example), in which particle size, particle concentration, and relative intensity are plotted together.
Table 2. Diameter Values of S. enteritidis and S. typhimurium GMMA Samples Analyzed by SEC-MALS
GMMA fraction 2 × Rn (nm) 2 × Rw (nm) 2 × Rz (nm)
SEn 618 ΔtolR ΔmsbB ΔpagP whole population 73.20 ± 0.88 74.60 ± 0.90 76.20 ± 0.91
HMM 78.60 ± 4.09 79.40 ± 4.05 80.20 ± 4.01
MMM 67.00 ± 1.01 68.40 ± 0.96 70.20 ± 0.98
LMM 58.00 ± 1.51 59.20 ± 1.48 61.20 ± 1.53
STm 2192 ΔtolR ΔpagP ΔmsbB whole population 68.20 ± 0.75 69.80 ± 0.77 72.20 ± 0.79
HMM 80.00 ± 0.96 81.00 ± 0.97 82.20 ± 0.99
MMM 67.60 ± 0.81 68.20 ± 0.82 70.00 ± 0.84
LMM 58.60 ± 0.94 59.80 ± 0.96 61.40 ± 0.98
STm 1418 ΔtolR whole population 70.00 ± 0.91 71.40 ± 0.86 73.80 ± 0.89
STm 1418 ΔtolR ΔwbaP whole population peak 1 98.20 ± 0.59 100.00 ± 0.60 101.80 ± 0.61
whole population peak 2 51.00 ± 1.08 52.60 ± 1.00 55.40 ± 1.00
Table 3. NTA Analysis of SEn ΔtolR ΔmsbB ΔpagP GMMA Analyzed at Diﬀerent Dilutions
sample dilution detection threshold protein concentration (μg/mL) mean (nm) mode (nm) particles (mL) particles (μg)
10 000× 3 1.39 × 10−1 106.05 86.65 2.55 × 109 1.83 × 1010
25 000× 7 5.82 × 10−2 108.40 90.85 1.10 × 109 1.90 × 1010
50 000× 11 2.90 × 10−2 105.15 97.65 5.54 × 108 1.91 × 1010
75 000× 11 1.93 × 10−2 106.65 85.90 3.57 × 108 1.85 × 1010
100 000× 14 1.45 × 10−2 103.90 98.40 2.82 × 108 1.95 × 1010
average 106.03 91.89 1.89 × 1010
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and mean diameters, by NTA. Such values were also similar to
the NTA mode diameters of the corresponding whole
populations.
For all of the OAg+ GMMA, the Z-average size measured by
DLS was higher compared to the 2 × Rz value obtained by
SEC-MALS. The same behavior was not found for ΔwbaP
OAg− GMMA, suggesting that higher values from DLS were
not only due to the higher weight of large particles in the
average diameter calculation by this method. The diﬀerence
observed could be related to the presence of the OAg chains
displayed on the GMMA surface, which play a role in
determining the behavior of GMMA in the solution. OAg+
GMMA were in fact characterized by diﬀerent Z-average
diameters, but similar SEC-MALS diameters of around 70 nm
(Table 5).
Number of OAg chains per GMMA particle, OAg length, and
structural characteristics such as O-acetylation and glucosyla-
tion level, as well as the amount of lipid A and its structure,
could aﬀect the overall size of GMMA. By looking at these
characteristics (Table 6), a correlation between DLS diameters
and average number of OAg chains per GMMA particle was
found (Figure 2A). The size of OAg chains was similar for all of
the OAg+ GMMA tested, and no correlation was found
between GMMA size and protein or lipid A content (Figure
2B,C).
Table 6 also reports the ζ-potential values collected for
diﬀerent GMMA. All of them can be considered approximately
neutral in phosphate buﬀered saline (PBS), with similar values
for all of the OAg-positive GMMA and a more negative value
for the OAg-negative sample. DLS allowed precise and reliable
GMMA particle size analysis within few minutes, with a rapid
and simple sample preparation and instrument setup. A major
drawback of DLS is that it is inherently sensitive to the
presence of large particles in the sample used in the analysis,23
as veriﬁed by analyzing the unfractionated and fractionated
GMMA samples. It is expected that the DLS Z-average size
distribution of polydisperse samples is biased by even a small
number of large particles because such particles scatter light
Table 4. NTA Results of SEn 618 ΔtolR ΔmsbB ΔpagP, STm 2192 ΔtolR ΔpagP ΔmsbB, STm 1418 ΔtolR, and STm 1418
ΔtolR ΔwbaP GMMA
GMMA sample mean (nm) mode (nm) SD D10 D50 D90 particles (μg)
SEn 618 ΔtolR ΔmsbB ΔpagP whole population 106.03 91.89 37.24 57.72 89.13 143.82 1.89 × 1010
MMM fraction 92.88 81.38 23.15 60.63 78.05 111.83 2.24 × 1010
STm 2192 ΔtolR ΔpagP ΔmsbB whole population 102.47 78.59 38.61 60.36 79.60 140.49 1.09 × 1010
MMM fraction 83.33 76.51 20.14 54.84 69.20 96.03 2.24 × 1010
STm 1418 ΔtolR whole population 95.80 85.64 31.58 56.96 79.63 120.58 1.47 × 1010
MMM fraction 84.93 74.53 31.67 50.67 68.70 104.73 7.18 × 1010
STm 1418 ΔtolR ΔwbaP whole population 90.13 62.63 48.23 37.17 70.07 134.33 3.32 × 109
Table 5. Summary of the Analyses Performed by DLS, SEC-MALS, and NTA on SEn 618 ΔtolR ΔmsbB ΔpagP, STm 2192
ΔtolR ΔpagP ΔmsbB, STm 1418 ΔtolR, and STm 1418 ΔtolR ΔwbaP GMMAa
DLS SEC-MALS NTA
GMMA sample
Z-average diameter
(nm) 2 × Rn (nm) 2 × Rw (nm) 2 × Rz (nm)
mean diameter
(nm)
mode diameter
(nm)
SEn 618 ΔtolR ΔmsbB
ΔpagP
whole
population
111.07 73.20 74.60 76.20 106.03 91.89
MMM fraction 91.28 67.00 68.40 70.20 92.88 81.38
STm 2192 ΔtolR ΔpagP
ΔmsbB
whole
population
103.47 68.20 69.80 72.20 102.47 78.59
MMM fraction 81.69 67.60 68.60 70.00 83.33 76.51
STm 1418 ΔtolR whole
population
91.53 70.00 71.40 73.80 95.80 85.64
MMM fraction na na na na 84.93 74.53
STm 1418 ΔtolR ΔwbaP whole
population
57.60 98.20/51.00 100.00/52.60 101.80/55.40 90.13 62.63
ana: not analyzed.
Table 6. Characterization of SEn 618 ΔtolR ΔmsbB ΔpagP, STm 2192 ΔtolR ΔpagP ΔmsbB, STm 1418 ΔtolR, and STm 1418
ΔtolR ΔwbaP GMMA Trying To Correlate GMMA Size with Their Main Features
GMMA sample OAg
lipid A
structure5
Z-average
(nm)
2 × Rz
(nm)
average μg
protein/GMMA
OAg size
(kDa)a
average number OAg
chains/GMMAb
average number lipid A
molecules/GMMAb
ζ-potential
(mV)
SEn 618 ΔtolR
ΔmsbB ΔpagP
OAg+ penta 111.07 76.20 5.30 × 1011 30.00 2812 16 960 −3.2
STm 2192 ΔtolR
ΔpagP ΔmsbB
OAg+ penta 103.47 72.20 9.19 × 1011 34.60 2204 21 527 −3.3
STm 1418 ΔtolR OAg+ hepta/hexa 91.353 73.80 6.78 × 1011 32.90 768 11 035 −2.7
STm 1418 ΔtolR
ΔwbaP
OAg− hepta/hexa 57.60 55.40 3.01 × 1010 49 248 −9.8
aOAg size was calculated by HPLC-SEC analysis on a TSK gel 3000 PWxl column using dextrans as standards. bAverage number of OAg chains per
GMMA particle was calculated by sugar quantiﬁcation by HPAEC-PAD and particles counting by NTA. Average number of lipid A molecules was
derived by HPLC-SEC/semicarbazide assay.7
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more eﬃciently than small ones.24,25 On the contrary, with
SEC-MALS, the diameter of the whole population better
reﬂects the size of the most abundant population.
SEC-MALS is also a rapid and robust method for GMMA
size characterization. It allows separation and qualitative
analysis of generally occurring contaminants, such as free
soluble proteins and DNA.
NTA is an alternative light-scattering technology that
simultaneously but individually tracks and analyzes the
trajectories of GMMA in suspension. NTA can detect small,
weakly scattering particles among large, strong-scattering ones
that would dominate the size distribution of a particle sample
analyzed by DLS. The mean size gives the average size of the
whole vesicles population and has a value similar to Z-average
diameter by DLS. But mode size characterizes the particle size
that appears most often within a given preparation.
NTA allows not only size determination but also counting of
the number of particles. However, for NTA analysis, a range of
parameters need to be adjusted both for video capture (camera
gain and shutter speed) and data elaborations (ﬁlter settings,
background subtraction, removal of blurring, minimum track
length, minimum expected particle size, and detection thresh-
old). This makes standardization of the NTA technique, which
is strongly operator dependent,17,23,26−28 diﬃcult to achieve.21
Our study conﬁrmed that detection threshold is one of the
parameters that can strongly aﬀect both size and count of
particles in NTA analysis.26 In particular, NTA analyses did not
show an acceptable reproducibility among experiments
performed using scalar-diluted samples at a ﬁxed detection
threshold value, both in GMMA size and concentration.
Figure 2. (A) Correlation between DLS Z-average diameters and MALS 2 × Rz values with the number of OAg chains per GMMA particle. (B) Lack
of correlation between DLS Z-average diameters and MALS 2 × Rz values with number of lipid A molecules per GMMA particle. (C) Lack of
correlation between DLS Z-average diameters and MALS 2 × Rz values and protein amount per GMMA particle.
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■ CONCLUSIONS
In conclusion, all of the three methods provide size
measurements based on absolute analyses of the samples in
solution, independent of the calibration standards.
DLS is the most rapid method, but SEC-MALS and NTA are
preferable in the case of bimodal samples, allowing better
separation of populations at diﬀerent size. MALS coupled with
SEC has also the advantage to detect eventual presence of
smaller mass impurities. NTA visualizes and counts single
particles also allowing determination of antigens density on
GMMA particle. In the speciﬁc case of S. typhimurium GMMA,
the number of OAg chains on the GMMA surface aﬀects the
hydrodynamic radius determined by DLS and mean size by
NTA, but not Rgeo by MALS.
To our knowledge, this is one of the ﬁrst studies describing
the use of NTA for OMV characterization29 and comparing the
use of diﬀerent techniques for their size determination.
Complete characterization of OMV size is an important
research topic in the ﬁeld of OMV vaccines development
because it is essential to check the consistency of production
and stability of samples, and to study diﬀerences among
bacterial strains. All of the techniques tested here provided
useful information for a more complete evaluation of the
GMMA size.
■ EXPERIMENTAL SECTION
Strains for GMMA Production. S. typhimurium isolate
SGSC1418 (LT-2 collection, University of Calgary), S.
typhimurium 2192 (SGSC2192, SARA collection), and S.
enteritidis SA618 (CEESA EASSA II collection of Quotient
Bioresearch Limited) were used as parent strains for GMMA
production.22 Mutants for GMMA production are described in
Table 7 and were obtained as previously described.5 tolR
deletion increases the GMMA release during bacteria growth,
wbaP deletion is associated with the loss of O-antigen (OAg)
chains resulting in an OAg-negative strain, whereas ΔpagP and
ΔmsbB mutations have an impact on lipid A acylation pattern
and are introduced to have a pure penta-acylated lipid A
detoxiﬁed GMMA.5
GMMA Production. GMMA were produced and puriﬁed as
previously described.5 After puriﬁcation, all of the GMMA
samples were suspended in phosphate buﬀered saline (PBS)
and then 0.22 μm ﬁltered. GMMA content was estimated as the
total protein content by micro Bicinchoninic Acid Protein
Assay (BCA). OAg quantiﬁcation was performed by high-
performance anion exchange chromatography with pulsed
amperometric detection (HPAEC-PAD) analysis, and OAg
size was calculated by HPLC-SEC analysis on a TSK gel 3000
PWxl column using dextrans as standards. Number of lipid A
molecules were derived by HPLC-SEC/semicarbazide assay, as
previously described.7
Dynamic Light Scattering (DLS). DLS measurements
were performed with a Malvern Zetasizer Nano ZS (Malvern,
Herremberg, Germany) equipped with a 633 nm He−Ne laser
and operating at an angle of 173°. Scattering light detected at
173° was automatically adjusted by laser attenuation ﬁlters. For
data analysis, the viscosity and refractive index (RI) of PBS
buﬀer solution (at 25 °C) were used. The software used to
collect and analyze the data was the Zetasizer software version
7.11. Temperature was set at 25 °C. Each sample (80 μL) at 50,
125, and 200 μg/mL protein content was characterized in
duplicates in single-use polystyrene microcuvette (ZEN0040,
Alfatest) with a path length of 10 mm. The hydrodynamic
diameter of GMMA was expressed by a Z-average value
(general purpose algorithm) of three measurements for each
replicate, providing also a PDI of the size values calculated. Size
distribution by intensity was preferred to measurements by
number or by volume to have more reproducible results and
because the RI values of GMMA were not known, respectively.
Size Exclusion Chromatography Coupled with Multi-
angle Light Scattering (SEC-MALS). GMMA samples were
analyzed by HPLC-SEC with Tosoh TSK gel G6000PW (30
cm × 7.5 mm) + G4000PW (30 cm × 7.5 mm) columns in
series equilibrated in PBS (PBS tablets, Medicago) and with in-
line UV, ﬂuorescence emission, and MALS detectors. A Wyatt
Dawn Heleos II MALS equipped with fused silica cell and a 660
nm laser source were used. A volume of 80 μL of samples with
concentrations of 100 μg/mL protein content were injected
and eluted with a ﬂow rate of 0.5 mL/min (run time 70 min).
All of the dilutions were made in PBS. MALS data were
collected using ASTRA 6 software (Wyatt Technology) with
“particles” template and analyzed using “Sphere” model. The
size of GMMA was expressed by the number average geometric
radius Rn, weight average geometric radius Rw, and Z-average
geometric radius Rz values.
Nanoparticle Tracking Analysis (NTA). NS300 Nano-
sight instrument (Malvern) equipped with a CMOS camera
and a 488 nm monochromatic laser beam was used. Data
acquisition and processing were performed using NTA software
3.2 build 3.2.16. Automatic settings for the minimum track
length, the minimal expected particle size and blur setting were
applied. Viscosity settings for water were applied and
automatically corrected for the temperature used. Measure-
ments were performed at room temperature ranging from 22 to
25 °C. Particles movement was analyzed by NTA software with
camera level at 16, slider shutter at 1300, and slider gain at 512.
Diﬀerent detection threshold values were tested and adjusted
for the sample appearance after dilution. For each sample, ﬁve
replicate videos of 30 s at 25 frames per second were collected,
generating ﬁve replicate histograms that were averaged. Several
dilutions of the samples were analyzed and duplicates were
recorded for every diluted sample. GMMA samples were PBS
diluted in low-binding Eppendorf tubes, and the dilutions were
prepared just before the analysis. Samples were gently mixed
and slowly injected in the sample chamber using a 1 mL syringe
over 5−10 s. The samples were recorded under controlled ﬂow,
using the NanoSight syringe pump (speed 20). Each video was
then analyzed to determine the respective mean and mode
(particle size that appears most often within a given
preparation) GMMA size. In addition to these values, standard
Table 7. Mutated Strains Used for GMMA Production and Their Abbreviations
strain abbreviation name strain characteristics genotype
STm 1418 ΔtolR overblebbing, wild type lipid A, OAg positive S. typhimurium 1418 ΔtolR::aph
STm 1418 ΔtolR ΔwbaP overblebbing, wild type lipid A, OAg negative S. typhimurium 1418 ΔtolR::aph ΔwbaP::cat
STm 2192 ΔtolR ΔpagP ΔmsbB overblebbing, detoxiﬁed lipid A, OAg positive S. typhimurium 2192 ΔtolR::aph ΔpagP::cat ΔmsbB::tetRA
SEn 618 ΔtolR ΔmsbB ΔpagP overblebbing, detoxiﬁed lipid A, OAg positive S. enteritidis 618 ΔtolR::aph ΔmsbB::tetRA ΔpagP::cat
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deviation (SD) and percentile undersize values (D10, D50, and
D90) were collected. SD, D10, D50, and D90 were measure of
the spread of particles size distribution within the samples. The
concentrations of samples are reported either as particles per
mL or particles per frame.
HPLC-SEC. To obtain more homogeneous GMMA samples,
a volume of 100 μL with a concentration of 1000 μg/mL
protein content was fractionated by HPLC-SEC. Tosoh TSK
gel G6000PW (30 cm × 7.5 mm) + G4000PW (30 cm × 7.5
mm) columns in series equilibrated in PBS (PBS tablets,
Medicago) were used with in-line UV detector. Samples were
eluted with PBS at a ﬂow rate of 0.5 mL/min (run time 70
min). GMMA peaks were fractionated in 1.7 mL low binding
Eppendorf tubes monitoring the 280 nm elution proﬁle and
collecting fractions at the rate of one tube per minute.
ζ-Potential. ζ-potential measurements were acquired on a
Malvern Nano ZS instrument (Zetasizer software ver. 7.11)
with the following sample settings: “Protein” as material, “PBS”
as dispersant, and “Smoluchowski” as F(ka) selection model.
The experiments were performed at 25 °C with 120 s as
equilibration time using a disposable folded capillary cell
(model DTS 1070) ﬁlled with 750 μL of sample. The
measurement duration was set as “automatic”, with a minimum
and maximum numbers of runs of 10 and 100, respectively, and
a measurement number of 3 with a 60 s delay. The attenuation
and voltage of measurement as well as the analysis model were
set as automatic. The samples were analyzed at 200 μg/mL
protein concentration diluted in PBS.
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